Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools Jan 4, 2024 02:23PM
Madryn Asset Management Presents Evidence Somalogic (SLGC) 'Ran a Flawed and Incomplete Review of Alternatives' Dec 26, 2023 09:15AM
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives Dec 26, 2023 09:15AM
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools Dec 24, 2023 09:30AM